Personal profile

Ancillary activities

  • Boehringer Ingelheim RCV GmbH | Wenen, Oostenrijk | Bestuurder | 2013-10-21
  • Boehringer Ingelheim RCV GmbH | Wenen, Oostenrijk | Bestuurder | 2013-10-21

Last update Ancillary Activities: Amsterdam (2018-01-24)

Research Output 2003 2013

  • 5 Article
  • 2 PhD Thesis - Research VU, graduation VU

Bispyrimidines as potent histamine H4 receptor ligands: delineation of structure activity relationships and detailed H4 receptor binding mode

Engelhardt, H., Schultes, S., de Graaf, C., Nijmeijer, S., Vischer, H. F., Zuiderveld, O. B., Dobler, J., Stachurski, K., Mayer, M., Arnhof, H., Scharn, D., Haaksma, E. J. J., de Esch, I. J. P. & Leurs, R. 2013 In : Journal of Medicinal Chemistry. 2013, 56, p. 4264-4276

Research output: Scientific - peer-reviewArticle

Combining quantum mechanical ligand conformation analys is and protein modeling to elucidate GPCR–ligand binding modes

Schultes, S., Engelhardt, H., Roumen, L., Zuiderveld, O. P., Haaksma, E. J. J., de Esch, I. J. P., Leurs, R. & de Graaf, C. 2013 In : ChemMedChem. 8, 1, p. 49-53

Research output: Scientific - peer-reviewArticle

Computational Medicinal Chemistry in Drug Discovery

Schultes, S. 2013

Research output: ScientificPhD Thesis - Research VU, graduation VU

Open Access
File

Design and Preparation of New Ligands Interacting with the Histamine H4 Receptor

Engelhardt, H. 2013

Research output: ScientificPhD Thesis - Research VU, graduation VU

Open Access
File